Annual Secretarial Compliance Report for 2025-26

TORNTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-1.1%1-day move

₹4497.00

prior close

₹4525.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+1.6+2.2+2.7+3.2-1.1+0.7-1.8-3.3-4.8-3.7-0.6+0.5+11.4—

Up moveDown movePending

AI summary

Torrent Pharmaceuticals has submitted its Annual Secretarial Compliance Report for FY 2025-26 under SEBI Regulation 24A(2). The report, issued by M/s. M. C. Gupta & Co., Practicing Company Secretaries, covers compliance with various SEBI regulations including LODR 2015, Takeover Regulations, Prohibition of Insider Trading Regulations, and Depositories Regulations. The secretarial auditor has verified compliance across 13 areas including secretarial standards, board policies, website disclosures, director disqualification status, subsidiary disclosures, document preservation, performance evaluation, related party transactions, and insider trading norms. All compliance requirements show YES status with no deviations or violations reported for the review period. No actions were taken by SEBI or stock exchanges against the company during the year. The report was signed on May 9, 2026 and filed with exchanges on May 23, 2026.

Likely market impact

This is a positive regulatory filing confirming Torrent Pharmaceuticals maintained full compliance with applicable SEBI regulations and secretarial standards throughout FY 2025-26. The clean compliance report with no adverse observations or pending actions is reassuring for investors regarding the company's corporate governance standards.